Welcome to the NASH blog
Bending the Cost Curve on Soaring Specialty Drug Costs
According to a recent Mercer study, the total health benefit cost per employee is projected to rise 6.5% in 2026. This is the highest increase since 2010 even after accounting for cost-reduction measures. The two leading concerns for benefit sponsors are 1) managing...
Tackling Specialty Drug Affordability: Empowering Self-Insured Employers to Regain Control Over Specialty Pharmacy Spend
The specialty drug affordability issue Prescription drug use and spend has been steadily increasing in the U.S. and around the world. In fact, less than 5% of the U.S. population requires treatment with specialty drugs, yet they account for over 50% of net drug...
Boosting Health Benefit Engagement: How Employers Can Encourage Employees to Maximize Their Savings
When employees use their health benefits, they have better health outcomes and miss less work. And with NASH, they also save money on expensive specialty medications. Employers also experience significant cost savings when employees take full advantage of their...